Get startedLog in
    Picture of Corcept Therapeutics Incorporated logo

    CORT — Corcept Therapeutics Incorporated News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And Bevacizumab

    Picture of Corcept Therapeutics Incorporated logoCorcept Therapeutics Incorporated
    07/04/2025 13:54
    April 7 (Reuters) - Corcept Therapeutics Inc CORT.O:

CORCEPT INITIATES TRIAL OF RELACORILANT PLUS NAB-PACLITAXEL AND BEVACIZUMAB IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER

CORCEPT THERAPEUTICS INC - BELLA TRIAL TO ENROLL 90 WOMEN WITH PLATINUM-RESISTANT OVARIAN CANCER

Source text: ID:nBw1r6n8la

Further company coverage: CORT.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Corcept Therapeutics Incorporated

    See all news